NXGN

NextGen Healthcare, Inc. [NXGN] Stock Forecast

Q: What is NextGen Healthcare, Inc. stock symbol ?

NextGen Healthcare, Inc. is a US stock, located in Atlanta of Ga and trading under the symbol NXGN

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

NXGN Stock Summary

Earnings have grown 9.53% per last year.

NXGN has more than 3 years of cash runway (36 months)

An RSI reading of 70 or higher indicates an overbought or overvalued condition.

Earnings are expected to fall -100% next year

EPS has been decreasing for the past 3 years (Yearly statements)

Profit margins (-0.01%) are lower than the previous year (-0%)

In the News

NXGN Financial details

Company Rating

Strong Buy

Market Cap

1.61B

Income

-6.21M

Revenue

695.05M

Book val./share

6.25

Cash/share

2.96

Dividend

Dividend %

Employees

2.78K

Optionable

Shortable

Yes

Earnings

22 Jan 2024

P/E

-258.41

Forward P/E

PEG

4.7

P/S

2.31

P/B

3.79

P/C

8.09

P/FCF

-37.06

Quick Ratio

2.22

Current Ratio

2.52

Debt / Equity

0.65

LT Debt / Equity

0.64

EPS (TTM)

-0.09

EPS next Y

EPS next Q

EPS this Y

-298%

EPS next Y

EPS next 5Y

EPS last 5Y

NAN%

Revenue last 5Y

4.3%

Revenue Q/Q

-1%

EPS Q/Q

-11.11%

SMA20

SMA50

SMA100

Inst Own

67.31%

Inst Trans

0.87%

ROA

-1%

ROE

-2%

ROC

0.01%

Gross Margin

46%

Oper. Margin

Profit Margin

-1%

Payout

Shs Outstand

Shs Float

Target Price

52W Range

15.23-23.98

52W High

+4.09%

52W Low

+59.6%

RSI

Rel Volume

2.48

Avg Volume

1.26M

Volume

3.12M

Perf Week

0.13%

Perf Month

Perf Quarter

Perf Half Y

0.46%

Beta

0.77

Volatility

0%, 0.04%

Prev Close

Price

23.94

Change

NXGN Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-03-31

Metric	2019-03-31	2020-03-31	2021-03-31	2022-03-31	2023-03-31
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	8.19	8.23	8.33	8.8	9.75
Net income per share	0.38	0.11	0.14	0.02	-0.04
Operating cash flow per share	0.78	1.3	1.47	0.79	0.65
Free cash flow per share	0.39	0.89	1.05	0.38	0.1
Cash per share	0.51	2.1	1.1	0.88	3.56
Book value per share	5.82	6.1	6.45	6.24	5.98
Tangible book value per share	1.03	0.59	1.29	1.29	-0.07
Share holders equity per share	5.82	6.1	6.45	6.24	5.98
Interest debt per share	0.61	2.75	0.52	0.32	4.19
Market cap	1.09B	684.99M	1.21B	1.42B	1.17B
Enterprise value	1.06B	725.42M	1.17B	1.38B	1.34B
P/E ratio	44.31	91.36	127.23	876.05	-439.55
Price to sales ratio	2.05	1.27	2.17	2.38	1.79
POCF ratio	21.5	8	12.29	26.47	26.72
PFCF ratio	43.49	11.67	17.25	55.67	182.39
P/B Ratio	2.89	1.71	2.8	3.35	2.91
PTB ratio	2.89	1.71	2.8	3.35	2.91
EV to sales	2.01	1.34	2.1	2.31	2.06
Enterprise value over EBITDA	28.67	28.52	16.67	25.77	25.36
EV to operating cash flow	21.06	8.47	11.86	25.73	30.75
EV to free cash flow	42.61	12.35	16.65	54.1	209.91
Earnings yield	0.02	0.01	0.01	0	0
Free cash flow yield	0.02	0.09	0.06	0.02	0.01
Debt to equity	0.1	0.45	0.07	0.05	0.69
Debt to assets	0.07	0.25	0.05	0.03	0.31
Net debt to EBITDA	-0.6	1.59	-0.6	-0.74	3.33
Current ratio	1.25	1.82	1.15	1.17	2.03
Interest coverage	11.24	10.89	5.94	7.43	2.58
Income quality	2.06	11.42	10.35	33.09	-16.45
Dividend Yield	0	0	0	0	0
Payout ratio	0	0	0	0	0
Sales general and administrative to revenue	0.3	0.29	0.32	0.34	0.33
Research and developement to revenue	0.15	0.15	0.14	0.13	0.13
Intangibles to total assets	0.58	0.5	0.54	0.53	0.45
Capex to operating cash flow	-0.51	-0.31	-0.29	-0.52	-0.85
Capex to revenue	-0.05	-0.05	-0.05	-0.05	-0.06
Capex to depreciation	-0.59	-0.56	-0.58	-0.66	-1.02
Stock based compensation to revenue	0.03	0.04	0.04	0.04	0.05
Graham number	7.05	3.96	4.54	1.83	2.31
ROIC	0.06	0.06	0.04	0.01	-0.01
Return on tangible assets	0.11	0.02	0.03	0.01	-0.01
Graham Net	-0.7	-1.55	-0.8	-0.71	-2.52
Working capital	31.62M	116.8M	27.01M	30.71M	203.71M
Tangible asset value	66.73M	38.52M	86.26M	87.61M	-4.81M
Net current asset value	2.9M	-59.61M	-5.2M	6.97M	-93.84M
Invested capital	0.1	0.45	0.07	0.05	0.69
Average receivables	98.73M	98.89M	95.59M	102.75M	110.51M
Average payables	4.82M	7.98M	10.95M	10.25M	10.57M
Average inventory	150K	10.23M	23.15M	28.55M	19.21M
Days sales outstanding	72	63.1	64.1	65.93	63.32
Days payables outstanding	8.04	14.36	15.08	11.27	12.83
Days of inventory on hand	0.18	27.75	34.4	38.49	7.76
Receivables turnover	5.07	5.78	5.69	5.54	5.76
Payables turnover	45.42	25.42	24.21	32.37	28.45
Inventory turnover	2.06K	13.15	10.61	9.48	47.05
ROE	0.07	0.02	0.02	0	-0.01
Capex per share	-0.4	-0.41	-0.42	-0.41	-0.56

Quarterly Fundamentals Overview

Last date of statement is 2023-09-30 for Q2

Metric	2022-09-30	2022-12-31	2023-03-31	2023-06-30	2023-09-30
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	2.33	2.41	2.7	2.67	2.61
Net income per share	0.2	0.12	-0.38	0.09	0.07
Operating cash flow per share	0.56	0.03	0.12	-0.12	-0.14
Free cash flow per share	0.41	-0.1	-0.01	-0.25	-0.28
Cash per share	1.03	3.59	3.61	3.26	2.96
Book value per share	6.46	6.21	6.06	6.14	6.25
Tangible book value per share	1.54	0.18	-0.07	0.08	0.25
Share holders equity per share	6.46	6.21	6.06	6.14	6.25
Interest debt per share	0.18	4.13	4.21	4.15	4.09
Market cap	1.21B	1.26B	1.15B	1.08B	1.61B
Enterprise value	1.15B	1.3B	1.33B	1.29B	1.83B
P/E ratio	22.22	40.44	-11.39	44.04	79.44
Price to sales ratio	7.6	7.81	6.44	6.08	9.1
POCF ratio	31.5	579.56	149.67	-133.92	-170.55
PFCF ratio	43.17	-182.11	-1.86K	-64.64	-84.48
P/B Ratio	2.74	3.03	2.87	2.64	3.79
PTB ratio	2.74	3.03	2.87	2.64	3.79
EV to sales	7.23	8.02	7.43	7.23	10.35
Enterprise value over EBITDA	38.96	64.22	-170.91	59.82	93.63
EV to operating cash flow	29.98	595.31	172.58	-159.08	-193.88
EV to free cash flow	41.09	-187.06	-2.15K	-76.78	-96.03
Earnings yield	0.01	0.01	-0.02	0.01	0
Free cash flow yield	0.02	-0.01	0	-0.02	-0.01
Debt to equity	0.03	0.66	0.69	0.67	0.65
Debt to assets	0.02	0.32	0.31	0.32	0.32
Net debt to EBITDA	-1.98	1.7	-22.69	9.46	11.26
Current ratio	1.29	2.53	2.03	2.23	2.52
Interest coverage	63.94	4.27	-5.93	3.78	2.43
Income quality	2.82	0.28	-0.3	-1.32	-1.86
Dividend Yield	0	0	0	0	0
Payout ratio	0	0	0	0	0
Sales general and administrative to revenue	0	0	0.41	0	0
Research and developement to revenue	0.13	0.12	0.11	0.12	0.1
Intangibles to total assets	0.54	0.47	0.45	0.47	0.47
Capex to operating cash flow	-0.27	-4.18	-1.08	1.07	1.02
Capex to revenue	-0.07	-0.06	-0.05	-0.05	-0.05
Capex to depreciation	-1.18	-1.03	-0.84	-0.93	-1.03
Stock based compensation to revenue	0.05	0.06	0.04	0.04	0.05
Graham number	5.38	4.03	7.22	3.57	3.24
ROIC	0.03	0.01	-0.03	0.01	0.01
Return on tangible assets	0.05	0.02	-0.05	0.01	0.01
Graham Net	-0.31	-1.91	-2.55	-2.31	-1.94
Working capital	49.53M	235.44M	203.71M	206.89M	218.92M
Tangible asset value	105.1M	12.31M	-4.81M	5.24M	16.92M
Net current asset value	32.85M	-63.62M	-93.84M	-83.22M	-71.68M
Invested capital	0.03	0.66	0.69	0.67	0.65
Average receivables	107.79M	105.69M	109.61M	111.05M	113.81M
Average payables	13.73M	13.46M	13.27M	12.1M	11.33M
Average inventory	18.14M	18.07M	7.59M	7.42M	17.58M
Days sales outstanding	59.54	58.88	57.11	54.94	60.61
Days payables outstanding	13.53	15.3	11.51	11.15	9.94
Days of inventory on hand	30.76	8.35	6.96	6.93	26.19
Receivables turnover	1.51	1.53	1.58	1.64	1.48
Payables turnover	6.65	5.88	7.82	8.08	9.06
Inventory turnover	2.93	10.78	12.94	12.98	3.44
ROE	0.03	0.02	-0.06	0.01	0.01
Capex per share	-0.15	-0.14	-0.13	-0.13	-0.14

NXGN Frequently Asked Questions

What is NextGen Healthcare, Inc. stock symbol ?

NextGen Healthcare, Inc. is a US stock , located in Atlanta of Ga and trading under the symbol NXGN

What is NextGen Healthcare, Inc. stock quote today ?

NextGen Healthcare, Inc. stock price is $23.94 today.

Is NextGen Healthcare, Inc. stock public?

Yes, NextGen Healthcare, Inc. is a publicly traded company.

Something similar

Top by Market Cap

Same Sector

Check Those

Similar Market Cap

Company Profile

Volume Average 1.26M
Market Capitalization 1.61B
Employee 2.78K
CEO Mr. David William Sides
Headquarters Atlanta,GA,US
IPO Date 1982-12-01
Website https://www.nextgen.com

NextGen Healthcare, Inc. provides healthcare technology solutions in the United States. The company offers clinical care solutions, including NextGen Enterprise EHR; financial solutions, such as NextGen Enterprise PM; patient engagement solutions comprising NextGen Virtual Visits; integrated clinical care and financial solutions consisting of NextGen Office; interoperability solutions that include NextGen Share and Mirth Connect; data and analytics solutions, which comprise NextGen Health Data Hub; and value based care solutions, including NextGen Population Health Solutions. It also provides managed services, such as revenue cycle management services comprising billing and collections, electronic claims submission and denials management, electronic remittance and payment posting, and accounts receivable follow-up; and client and support services. Further, the company offers professional services consisting of training, project management, installation services, and application managed services; and consulting services that include physician, professional, and technical consulting; assisting clients to optimize their staffing and software solutions; enhancing financial and clinical outcomes; achieving regulatory requirements; and meeting the requirements of healthcare reform. It serves accountable care organizations, independent physician associations, managed service organizations, veterans service organizations, dental service organizations, ambulatory care centers, and community health centers through a direct sales force and reseller channel. The company was formerly known as Quality Systems, Inc. and changed its name to NextGen Healthcare, Inc. in September 2018. NextGen Healthcare, Inc. was incorporated in 1974 and is headquartered in Atlanta, Georgia.